Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.62T
24h Vol:
$3.20B
Dominance:
MSFT:5.15%
Stocklytics Platform
BETA
Instrument logo  CAPR

Capricor Therapeutics Inc

CAPR
60 / 100
Penny Stock
$4.33arrow_drop_up9.34%$0.37

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Capricor Therapeutics Inc (CAPR) Stocklytics Forecast

Capricor Therapeutics Inc (CAPR) is an innovative biotechnology company focused on the development of novel therapeutics for the treatment of rare diseases. With a strong pipeline of potential breakthrough drugs, CAPR is positioned to deliver significant value to its shareholders. The company's stock price has shown promising growth in recent years, and there are several factors that suggest this positive trend will continue in the future.

One of the key drivers of CAPR's future price growth is its robust product portfolio. The company has a diverse range of therapeutics in various stages of development, targeting different rare diseases. These potential treatments have shown promising results in preclinical and clinical trials, indicating their potential for commercial success. With the successful development and commercialization of these products, CAPR could experience a significant increase in its stock price.

add Capricor Therapeutics Inc to watchlist

Keep an eye on Capricor Therapeutics Inc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is the analyst price prediction for Capricor Therapeutics Inc (CAPR) stock?

Currently, there are no available analyst price predictions for Capricor Therapeutics Inc (CAPR). This absence of data could be due to various factors such as the lack of recent analyst reviews or updates.

question_mark
What are the analyst ratings for Capricor Therapeutics Inc (CAPR) stock?

Currently, there are no analyst ratings available for Capricor Therapeutics Inc (CAPR), possibly due to insufficient coverage or recent updates.

question_mark
What is the AI price prediction for Capricor Therapeutics Inc (CAPR) stock?

At present, there is no AI or machine-learning-based price prediction available for Capricor Therapeutics Inc (CAPR) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.